Skip to main content

Table 2 Clinical and pathologic response to TPF induction chemotherapy according to Annexin A1 expression

From: Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade

 

Annexin A1 expression

Chi-square

Low

High

test P value

Clinical response

32

50

0.300

Clinical non-response

5

14

Favorable pathologic response

7

20

0.177

Unfavorable pathologic response

30

44